Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism α7 receptor modulators(Neuronal acetylcholine receptor protein alpha-7 subunit modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H18F2N6O3 |
InChIKeyIURMHZBQEYNQOH-UHFFFAOYSA-N |
CAS Registry953428-73-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Tobacco Use Disorder | Phase 2 | - | - | |
Tobacco Use Disorder | Phase 2 | - | - | |
Tobacco Use Disorder | Phase 2 | - | - | |
Alzheimer Disease | Preclinical | DE | 01 Aug 2009 | |
Cognition Disorders | Preclinical | DE | 01 Aug 2009 | |
Schizophrenia | Preclinical | DE | 01 Aug 2009 | |
Smoking Cessation | Preclinical | US | - | - |
Depressive Disorder | Discovery | MD | 01 Feb 2016 | |
Depressive Disorder | Discovery | RO | 01 Feb 2016 |
Phase 2 | 62 | Placebo Pill+Active JNJ Drug (Active JNJ Drug) | zqzzdczxmg(rsbrxdmjfd) = fdgvhwyxqx auwhqwksxo (hwdvmwsuwv, mubxjnfwed - qgypceoiav) View more | - | 30 Jan 2018 | ||
Placebo Pill+Active JNJ Drug (Placebo Pill) | zqzzdczxmg(rsbrxdmjfd) = ptlrluhobr auwhqwksxo (hwdvmwsuwv, gebdpbbebk - pxfsyhwtdl) View more |